跳至主要内容
临床试验/NCT05233098
NCT05233098已完成不适用

TheraSphere Post-approval Study to Calculate the Radiation-absorbed Dose of Technetium-99m Macroaggregated Albumin (Tc-99m MAA) to the Whole Body and Non-liver Critical Organs.

Boston Scientific Corporation1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2022年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6
试验地点
1
主要终点
Delivered Activity of Tc-99m MAA (MBq) for Whole Body

研究概览

简要总结

The TheraSphere Post-Approval Study is a post-market, prospective, single-arm, open-label, observational study to support the use of TheraSphere for the treatment of hepatocellular carcinoma (HCC).

详细描述

Every patient being treated with TheraSphere needs to have a screening procedure with the administration of a radioactive product named Tc-99m MAA (called pre-treatment mapping). This screening procedure aims to determine if the patient can be treated with TheraSphere. The purpose of this study is to better understand the dose of radiation that is absorbed by the body and the risk of Tc-99m MAA to the whole body and other organs around the liver. The study will determine the amount of Tc-99m MAA that stays in the body and organs up to 24 hours after the administration.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 21 years and older
  • Written informed consent
  • Patients who receive Tc-99m MAA while being evaluated for TheraSphere treatment.

排除标准

  • Patients who are contraindicated for TheraSphere treatment.
  • Patients who are contraindicated for Tc-99m MAA per the applicable Package Insert.
  • Patients who do not receive Tc-99m MAA during pre-treatment Y-90 mapping

结局指标

主要结局

Delivered Activity of Tc-99m MAA (MBq) for Whole Body

时间窗: 4 hours +/- 2 hours

To provide imaging data to calculate the radiation-delivered dose of Tc-99m MAA to the whole body.

Delivered Activity of Tc-99m MAA (MBq) for Non-Liver Critical Organs

时间窗: 18-24 hours

To provide imaging data to calculate radiation delivered dose of Tc-99m MAA to the whole body and to potential irradiated non-liver critical organs.

Delivered Activity of Tc-99m MAA (MBq) for Non-Liver Critical Organs.

时间窗: 4 hours +/- 2 hours

To provide imaging data to calculate the radiation-delivered dose of Tc-99m MAA to the whole body and to potential irradiated non-liver critical organs.

Delivered Activity of Tc-99m MAA (MBq) for Whole Body.

时间窗: 18-24 hours

To provide imaging data calculating radiation-delivered dose of Tc-99m MAA to the whole body following injection.

Absorbed Dose of Tc-99m MAA (mGy) for Whole Body.

时间窗: Overall

To provide imaging data calculating radiation-absorbed dose of Tc-99m MAA to the whole body.

Equivalent Dose of TC-99m MAA (mSV) for Non-Liver Critical Organs

时间窗: Overall

To provide imaging data calculating radiation-equivalent dose of Tc-99m MAA to Non-Liver Critical Organs.

Absorbed Dose of Tc-99m MAA (mGy) for Non-Liver Critical Organs

时间窗: Overall

To provide imaging data calculating radiation-absorbed dose of Tc-99m MAA to Non-Liver Critical Organs.

Effective Dose of Tc-99m MAA (mSv) Whole Body

时间窗: Overall

To provide imaging data calculating radiation-effective does of Tc-99m MAA to Non-Liver Critical Organs.

Effective Dose of Tc-99m MAA (mSv/mBq) for Whole Body

时间窗: Overall

To provide data calculating radiation-effective dose of Tc-99m MAA to Whole Body.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

TheraSphere Post-Approval Study to Calculate the... | 临床试验